Europe — EMA

Pantoprazol Krka (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Krka, is a proton pump inhibitor presented as a unknown strength/unknown form for oral use.

Pantoprazole

Request sourcing

Pack/s

What is Pantoprazole?

Pantoprazole, the active ingredient in Pantoprazol Krka, is a proton pump inhibitor presented as a unknown strength/unknown form for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Pantoprazol Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Pantoprazole used for?

Pantoprazol Krka is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for: - Gastro‑oesophageal reflux disease (GERD): relief of symptoms and healing of erosive erosion and ulcers at the esophagus and stomach by reducing acid exposure . - Peptic ulcer disease (PUD) (including c ....

What are the side effects of Pantoprazole?

Common ...

What precautions apply to Pantoprazole?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →